Table 2.
Subject | Clopidogrel dose | Timing of dose in relation to 1st blood draw |
---|---|---|
P4-012 | 600 mg | 42 min after |
P4-022 | 600 mg | 2 min before |
P4-031 | 600 mg | 173 min after |
P4-045 | 300 mg | 80 min after |
P4-046 | 300 mg | 149 min after |
P4-047 | Unknown dose | Post-procedurea |
P4-048 | 600 mg | 18 min before |
P4-050 | 300 mg | 32 min after |
P4-054 | 600 mg | 6 min before |
P4-055 | 600 mg | 36 min after |
P4-056 | 600 mg | 28 min after |
P4-057 | 600 mg | 31 min after |
P4-058 | 600 mg | 38 min after |
Eight of the patients were categorized as clopidogrel naïve as they received the loading dose of clopidogrel (either 300 or 600 mg of clopidogrel) at the end of the intervention after the post bivalirudin blood draw. Six of the patients were categorized as clopidogrel-naïve as they received the loading dose within 35 min of the timing of sampling for the first blood draw
Details of the timing or dose of clopidogrel not available, but patient did receive clopidogrel post-procedurally. The patients classified as being on clopidogrel, were on chronic clopidogrel having received clopidogrel daily for at least 7 days prior to presentation